Viewing Study NCT03206203


Ignite Creation Date: 2025-12-24 @ 7:16 PM
Ignite Modification Date: 2026-01-04 @ 12:37 PM
Study NCT ID: NCT03206203
Status: COMPLETED
Last Update Posted: 2024-12-12
First Post: 2017-06-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer
Sponsor: Vanderbilt-Ingram Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Triple Negative Breast Cancer View
None Stage IV Breast Cancer View
None HER2 Negative View
None Invasive Breast Cancer View
Keywords: